Alzheimer's Disease

Understanding Alzheimer’s Disease

Alzheimer’s disease is a neurological disorder in which the brain slowly degenerates, leading to problems with memory, daily function and behavior.

Alzheimer’s disease overview

Alzheimer’s disease is a progressive brain disorder, in which the brain gradually degenerates. It most frequently occurs in people aged above 65 years.

 

Over the course of the disease, areas of the brain degenerate, resulting in cellular loss and dysfunction, a gradual loss of memory, problems with reasoning or judgment, disorientation, difficulty in learning, loss of language skills and decline in the ability to perform routine tasks.2-3 These changes increasingly impact upon the person’s daily life, reducing their independence, until ultimately, they are entirely dependent on others.2

 

Alzheimer’s disease also has an enormous impact on those who care for an individual with Alzheimer’s disease.4 Most caregivers are close relatives who provide care in the home – a demanding and exhausting role that represents a huge emotional and physical burden.3-4

Facts about Alzheimer’s

Alzheimer’s disease is one of Lundbeck’s focus disease areas, and is the most common neurodegenerative disorder. Symptoms of Alzheimer’s disease can be broadly categorized into cognitive, functional and behavioural/psychological changes. Over the course of the disease, areas of the brain degenerate, resulting in cellular loss and dysfunction, a gradual loss of memory, problems with reasoning or judgment, disorientation, difficulty in learning, loss of language skills and decline in the ability to perform routine tasks.1-2

Alzheimer’s disease is the most common neurodegenerative disorder and occurs most frequently in people over 65 years.2

Symptoms

The symptoms of Alzheimer’s disease emerge gradually, over a period of years, and vary from person to person.3 The first symptoms to appear are usually forgetfulness and mild confusion.3 Symptoms of Alzheimer’s disease can be broadly categorized into cognitive, functional and behavioral/psychological changes:

 

  • Cognitive changes – impaired short-term memory (such as impaired knowledge of recent events, repeating oneself, losing items around the house, poor organization), difficulty in making decisions, reduced understanding of the concept of time and space, reduced ability to learn and problems recognizing friends and family.3, 5-6   
  • Functional changes – reduced ability to perform daily activities: difficulty handling money, travelling and self-care (eating, getting dressed, maintaining personal hygiene) as well as problems with balance and unsteady movements.3,7 Ultimately, those with Alzheimer’s disease will usually become completely dependent on caregivers.3,7
  • Behavioral/psychiatric changes – patients may also develop behavioral disturbances, which increase the burden of care. It includes withdrawal from social activities, apathy/indifference, depressed mood, anxiety, and agitation.3 Behavioral changes are particularly difficult for family and carers to cope with, and are often the reason for patients being moved to institutional care.9

Early warning signs (10)

1. Memory loss that disrupts daily life

2. Challenges in planning or solving problems

3. Difficulty completing familiar tasks at home, at work or at leisure

4. Confusion with time or place

5. Trouble understanding visual images and spatial relationships

6. New problems with words in speaking or writing

7. Misplacing things and losing the ability to retrace steps

8. Decreased or poor judgment

9. Withdrawal from work or social activities

10. Changes in mood and personality

50 m

people worldwide have dementia (Alzheimer's disease is the most common cause of dementia and may contribute to 60-80% of cases).3

USD 818 bn

The estimated total global societal cost of dementia, rising to USD 2 trillion by 2030.2

Epidemiology and burden

Worldwide, over 55 million people have dementia.¹ With the shift towards an older aged population,² there are nearly 10 million new cases every year.¹ A global collaboration of researchers have projected that by 2050, 153 million people worldwide will be living with Alzheimer’s disease or dementia.³

 

Alzheimer’s disease is the most common cause of dementia, accounting for 60-70% of dementia cases.¹ The annual worldwide cost of dementia is now greater than USD 1.3 trillion, and is expected to rise to USD 2.8 trillion by 2030.⁴

People who are concerned that they – or their loved ones – are experiencing symptoms of Alzheimer’s disease should see their doctor for help and advice.

Diagnosis and care

Alzheimer’s disease is diagnosed using patient and caregiver interviews; sometimes blood tests and brain imaging techniques are also performed. There are numerous assessment scales that can be used to identify the symptoms, and severity, of the disease.

 

Alzheimer's has no current cure, but treatments for symptoms are available and research continues.1 Although current Alzheimer's treatments cannot stop Alzheimer's from progressing, they can temporarily slow the worsening of dementia symptoms and improve quality of life for those with Alzheimer's and their caregivers.1 Today, there is a worldwide effort under way to find better ways to treat the disease, delay its onset, and prevent it from developing.1

1.    World Health Organization. Dementia fact sheet. 2023. Available at: https://www.who.int/en/news-room/fact-sheets/detail/dementia. Accessed February 2024.
2.   World Health Organization. Ageing and health fact sheet. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed February 2024.
3.   GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022; 7(2): e105–e125.
4.   Alzheimer’s Disease International. Dementia statistics. 2020. Available at: https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/. Accessed February 2024.
5.   Joubert S, Joncas S, Barbeau E, et al. Cognition. In: Gauthier S (ed.). Clinical Diagnosis and Management of Alzheimer’s Disease, Third Edition. Oxon: Informa Healthcare, 2007.
6.   Rainville C, Caza N, Belleville S, Gilbert B. Neuropsychological assessment. In: Gauthier S (ed.). Clinical Diagnosis and Management of Alzheimer’s Disease, Third Edition. Oxon: Informa Healthcare, 2007.
7.    Sarazin M, Horne N, Dubois B. Natural decline and prognostic factors. In: Gauthier S (ed.). Clinical Diagnosis and Management of Alzheimer’s Disease, Third Edition. Oxon: Informa Healthcare, 2007.
8.    Gélinas I. Functional autonomy. In: Gauthier S (ed.). Clinical Diagnosis and Management of Alzheimer’s Disease, Third Edition. Oxon: Informa Healthcare, 2007.
9.    Teng E, Cummings JL. Behaviour. In: Gauthier S (ed.). Clinical Diagnosis and Management of Alzheimer’s Disease, Third Edition. Oxon: Informa Healthcare, 2007.
10.  Alzheimer’s Association. 10 Early Signs and Symptoms of Alzheimer’s: https://www.alz.org/alzheimers-dementia/10_signs.

Doreen Monks living with Alzheimer's disease

A long to-do list

More from lundbeck

Research and Development

R&D of new and improved treatments is at the core of what we do.

Our Commitment

We are committed to providing transformative outcomes to people living with brain disease.

Sustainability

Lundbeck remains committed to sustainability through our strong strategy.